Galapagos N.V. (ADR)
General ticker "GLPG" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.1B (TTM average)
Galapagos N.V. (ADR) does not follow the US Stock Market performance with the rate: -21.1%.
Estimated limits based on current volatility of 1.9%: low 27.29$, high 28.34$
Factors to consider:
- Total employees count: 435 as of 2015
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [25.22$, 43.73$]
- 2026-12-31 to 2027-12-31 estimated range: [24.60$, 43.00$]
Financial Metrics affecting the GLPG estimates:
- Positive: with PPE of 3.9 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of -10.23 <= 0.30
- Positive: Operating profit margin, % of 45.08 > 18.65
- Negative: 0.01 < Interest expense per share per price, % of 0.12
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 11.86 > -0.65
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 94.99 > 63.79
Short-term GLPG quotes
Long-term GLPG plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €239.72MM | €275.65MM | €1,112.25MM |
| Operating Expenses | €327.99MM | €463.99MM | €610.86MM |
| Operating Income | €-88.26MM | €-188.34MM | €501.39MM |
| Non-Operating Income | €93.89MM | €185.25MM | €-200.52MM |
| Interest Expense | €1.65MM | €0.91MM | €2.22MM |
| R&D Expense | €241.29MM | €335.46MM | €459.42MM |
| Income(Loss) | €5.62MM | €-3.08MM | €300.87MM |
| Taxes | €9.61MM | €-1.80MM | €-18.62MM |
| Net Income(Loss)* | €211.70MM | €74.08MM | €320.88MM |
| Stockholders Equity | €2,795.57MM | €2,896.94MM | €3,234.49MM |
| Inventory | €73.98MM | €51.19MM | €0.00MM |
| Assets | €4,357.40MM | €4,135.72MM | €3,405.07MM |
| Operating Cash Flow | €-405.97MM | €-320.03MM | €-189.23MM |
| Capital expenditure | €19.27MM | €82.11MM | €13.16MM |
| Investing Cash Flow | €71.19MM | €220.60MM | €219.35MM |
| Financing Cash Flow | €-5.00MM | €-4.92MM | €-3.14MM |
| Earnings Per Share** | €3.21 | €1.12 | €4.85 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.